指南与共识乳腺技术与安全乳腺X线

ACR适宜性标准®:无症状女性I期乳腺癌的初始检查及局部复发与远处转移监测

ACR Appropriateness Criteria® Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women.
PubMed 文献 · J Am Coll Radiol · 2019-01-01

美国放射学会(ACR)适宜性标准指出,新诊断的0~II期乳腺癌无症状患者(即使有淋巴结受累)不应进行分期影像检查;有I期乳腺癌病史且接受根治性治疗的无症状患者,影像筛查远处复发无作用;唯一应进行的影像监测是每年一次乳腺X线摄影,以发现乳腺内复发或新发原发乳腺癌。

要点

  • 新诊断0~II期乳腺癌无症状患者,即使有淋巴结受累,也不推荐分期影像检查。
  • I期乳腺癌根治性治疗后无症状患者,影像筛查远处复发无作用。
  • 有I期乳腺癌病史的女性,唯一应进行的影像监测是每年一次乳腺X线摄影。

核心结论

  • 新诊断0~II期乳腺癌无症状患者(即使有淋巴结受累),不推荐分期影像检查;不必要的影像可能延误治疗并影响结局。
  • 有I期乳腺癌病史且接受根治性治疗的无症状患者,影像筛查远处复发无作用。
  • 有I期乳腺癌病史的女性,唯一应进行的影像监测是每年一次乳腺X线摄影,以发现乳腺内复发或新发原发乳腺癌。

研究设计与样本

  • 美国放射学会(ACR)适宜性标准,基于证据的指南,由多学科专家小组每年审查。
  • 指南制定与修订包括对同行评审期刊当前医学文献的广泛分析,并应用RAND/UCLA适宜性方法和GRADE对特定临床场景的影像与治疗操作适宜性进行评级。
  • 证据缺乏或模棱两可时,专家意见可补充现有证据来推荐影像或治疗。

诊断标准与关键数值

  • 新诊断0~II期乳腺癌无症状患者(即使有淋巴结受累),不推荐分期影像检查。
  • 有I期乳腺癌病史且接受根治性治疗的无症状患者,不推荐影像筛查远处复发。
  • 有I期乳腺癌病史的女性,唯一应进行的影像监测是每年一次乳腺X线摄影,以发现乳腺内复发或新发原发乳腺癌。

临床应用与阅片要点

  • 新诊断0~II期乳腺癌无症状患者(即使有淋巴结受累),不应进行分期影像检查。
  • 有I期乳腺癌病史且接受根治性治疗的无症状患者,不应进行影像筛查远处复发。
  • 有I期乳腺癌病史的女性,应每年进行一次乳腺X线摄影监测乳腺内复发或新发原发乳腺癌。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

As the proportion of women diagnosed with early stage breast cancer increases, the role of imaging for staging and surveillance purposes is considered. National and international guidelines discourage the use of staging imaging for asymptomatic patients newly diagnosed with stage 0 to II breast cancer, even if there is nodal involvement, as unnecessary imaging can delay care and affect outcomes. In asymptomatic patients with a history of stage I breast cancer that received treatment for curative intent, there is no role for imaging to screen for distant recurrences. However, routine surveillance with an annual mammogram is the only imaging test that should be performed to detect an in-breast recurrence or a new primary breast cancer in women with a history of stage I breast cancer. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Lewin AA, Moy L, Baron P, et al. ACR Appropriateness Criteria® Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women. J Am Coll Radiol. 2019. PMID: 31685110. doi:10.1016/j.jacr.2019.05.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。